Eric Topol

Eric Topol

Creator
0 followers

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

Orforglipron Outperforms Other Oral GLP‑1s in T2D Trial
SocialFeb 26, 2026

Orforglipron Outperforms Other Oral GLP‑1s in T2D Trial

Head-to-head trial of the oral GLP-1 drugs in people with T2D. Orforglipron was superior https://t.co/9B7RXIgdJY

By Eric Topol
Progress Toward Off‑the‑Shelf Vaccines for Hereditary Cancer
SocialFeb 26, 2026

Progress Toward Off‑the‑Shelf Vaccines for Hereditary Cancer

We're making headway for off the shelf preventive cancer vaccines in people with hereditary forms of cancer, e.g. Lynch syndrome https://t.co/F3LqKS46BQ

By Eric Topol
GLP‑1 Drugs Plus Healthy Habits Cut Heart Events
SocialFeb 25, 2026

GLP‑1 Drugs Plus Healthy Habits Cut Heart Events

The combination of GLP-1 drugs (such as Ozempic) and healthy lifestyle factors was associated with less major adverse cardiovascular events in ~100,000 people with T2D @TheLancetEndo https://t.co/phNzEBy7zY https://t.co/DDVi8uedRP

By Eric Topol
Stem Cell Therapy Boosts Frailty Walk Test Performance
SocialFeb 25, 2026

Stem Cell Therapy Boosts Frailty Walk Test Performance

A randomized trial of a stem cell therapy vs placebo for aging frailty showed durable and dose-dependent improvement in the 6-minute walk test @CellStemCell https://t.co/2jOYuIgUrY https://t.co/04mEV7OdLo

By Eric Topol
Super Agers Generate More Neurons Than Much Younger Adults
SocialFeb 25, 2026

Super Agers Generate More Neurons Than Much Younger Adults

New @Nature The brains of Super Agers produce more neurons than people some 40 years younger, a neurogenesis resilient signature linked to exceptional cognitive health and memory skills https://t.co/tNB0dTea2F

By Eric Topol
Combining EMR and Multi‑omics Sharpens Biological Age Predictions
SocialFeb 25, 2026

Combining EMR and Multi‑omics Sharpens Biological Age Predictions

Assessment of biological age integrating electronic medical records and multi-omics increases accuracy for predicting outcomes @NatureAging https://t.co/7y60SSPTQf https://t.co/u02OlWMdQz

By Eric Topol
Circulating piRNAs May Predict Elderly Survival and Longevity
SocialFeb 25, 2026

Circulating piRNAs May Predict Elderly Survival and Longevity

Strong claim that needs independent replication: "Our findings provide compelling evidence that circulating smRNAs—especially piRNAs—are powerful predictors of survival in older adults and potential biomarkers of longevity" https://t.co/oi4220zxGY https://t.co/yk3MX4VdQj

By Eric Topol
CRISPR Unlocks Causal Insights Into Immune Complexity
SocialFeb 22, 2026

CRISPR Unlocks Causal Insights Into Immune Complexity

The complexity of our immune system is daunting. But there's a path to deconvolute it and understand causal relationships. It's CRISPR. open-access @JExpMed https://t.co/QF6Cvkbfz2 https://t.co/OTL2z1fow0

By Eric Topol
Combined DNA and Methylation Analysis Reveals Colon Cancer Risks
SocialFeb 21, 2026

Combined DNA and Methylation Analysis Reveals Colon Cancer Risks

By systematically assessing both DNA sequence variants and methylation, we're learning a lot more about risk of (and protection from) colon cancer @ScienceAdvances https://t.co/eA0Y0lrntr https://t.co/5iL4sg0rRC

By Eric Topol
Monocyte IL‑10 Explains Sex Differences in Pain Duration
SocialFeb 20, 2026

Monocyte IL‑10 Explains Sex Differences in Pain Duration

Sex differences in pain duration Finding interleukin-10 from monocytes as an/the explanation (in the experimental model and people) @SciImmunology https://t.co/fOsciwav7Y

By Eric Topol
Nasal Mucosa Targeted for Universal Respiratory Vaccine
SocialFeb 20, 2026

Nasal Mucosa Targeted for Universal Respiratory Vaccine

How to get a universal vaccine vs respiratory threats? Block via the nasal mucosa @ScienceMagazine https://t.co/IjCkbF05LB @NatRevImmunol https://t.co/2W7SZ1fHSR https://t.co/XcEzcMeXrB

By Eric Topol
Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy
SocialFeb 20, 2026

Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy

A cyborg pancreatic islet-cell implant takes the stem cell strategy to a new level of precision and potential future therapy for T1 diabetes @ScienceMagazine https://t.co/gkmsrzU1e4 https://t.co/qgegRPlEIl

By Eric Topol
Screening Cuts Advanced Colon Cancer, Boosts Early Detection
SocialFeb 20, 2026

Screening Cuts Advanced Colon Cancer, Boosts Early Detection

Screening works for colon cancer. Largest trial ever done. Today @NatureMedicine A randomized trial of colon cancer screening by colonoscopy or occult blood (FIT) vs control in nearly 280,000 participants showed signficantly more early diagnosis (stage I-II) and less stage...

By Eric Topol
EBV DNA Linked to Multiple Autoimmune Diseases in 800k Genomes
SocialFeb 19, 2026

EBV DNA Linked to Multiple Autoimmune Diseases in 800k Genomes

🆕@Nature Genome sequencing of >800,000 people finds Epstein-Barr virus reads and their association with other autoimmune diseases besides multiple sclerosis, including type 1 diabetes, inflammatory bowel disease, and hypothyroidism https://t.co/FKCV4OInT5

By Eric Topol
Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy
SocialFeb 19, 2026

Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy

The most used multicancer early detection (MCED) blood test (liquid biopsy) uses methylation (GRAIL). But combining that with DNA fragmentomics, as reported today @NatureCancer, improves early detection https://t.co/VkNDR4XuW3

By Eric Topol
Blood P‑tau217 Test Predicts Alzheimer’s Symptoms 20 Years Ahead
SocialFeb 19, 2026

Blood P‑tau217 Test Predicts Alzheimer’s Symptoms 20 Years Ahead

Predicting when symptoms of Alzheimer's disease will occur with elevated p-tau217 blood test and a person's age, even 20+ years in advance @NatureMedicine https://t.co/EYaGglBh1H

By Eric Topol
AI Automates Cytology, Streamlining Cell Pre‑Screening
SocialFeb 18, 2026

AI Automates Cytology, Streamlining Cell Pre‑Screening

AI automates cytology, which is a laborious, manual, human subjective task, for pre=screening cells for abnormalities and making initial diagnoses today @Nature https://t.co/ZI3F2pkMxE https://t.co/WsUcRjkHFN https://t.co/mdz1DM6xs7

By Eric Topol
Brain’s Venous Sinuses Patrol Immune Cells and Drain Fluid
SocialFeb 18, 2026

Brain’s Venous Sinuses Patrol Immune Cells and Drain Fluid

What's ruffling? Large veins interfacing the skull (venous sinuses) that patrol immune cells and help drain the brain https://t.co/WsML3Jd1yA

By Eric Topol
MRNA Vaccines Advance Triple‑negative Breast Cancer Therapy
SocialFeb 18, 2026

MRNA Vaccines Advance Triple‑negative Breast Cancer Therapy

The unfounded move by @HHSGov against mRNA vaccines will hurt our future potent immune therapy vs cancer. Another point of progress for triple-negative breast cancer with individualized neoantigen mRNA vaccines today @Nature Adds to successful pancreatic, renal cell, melanoma reports...

By Eric Topol
Listen to Biology’s Early Whispers to Prevent Disease
SocialFeb 18, 2026

Listen to Biology’s Early Whispers to Prevent Disease

We could prevent diseases so much better but we haven't learned to listen to when biology whispers long (10 + years) in advance. A key theme in Super Agers, too. https://t.co/0pSap3f32N @NathanPriceSci @ @nrappapo @BuckInstitute example below for Type 2...

By Eric Topol
Agentic AI Enables Accurate Rare Disease Diagnosis via DeepRare
SocialFeb 18, 2026

Agentic AI Enables Accurate Rare Disease Diagnosis via DeepRare

Another good use case for agentic AI in medicine: diagnosis of rare diseases. Exemplified by DeepRare https://t.co/XBd68V3iDl https://t.co/rBl5yn95sI

By Eric Topol
GLP‑1 Safety: New Data Highlights Retinal Risks
SocialFeb 17, 2026

GLP‑1 Safety: New Data Highlights Retinal Risks

A short thread on GLP-1s based on new publications. 1. The safety story Table of potential side effects and very good description of mechanisms, especially w/r to retina https://t.co/L5GNZyArrn https://t.co/MyXVOF3SYv

By Eric Topol
Free, Ad‑free Biomed Insights Reaching 200k Globally
SocialFeb 16, 2026

Free, Ad‑free Biomed Insights Reaching 200k Globally

Ground Truths are free essays and podcasts on the hot topics in biomedicine and health. Mostly things the media doesn't cover or adequately highlight. No ads or sponsors. Join ~200,000 subscribers from 212 countries https://t.co/ZgnO2Y0P4L

By Eric Topol
B‑Cell Depletion: Rebooting Immunity to Cure Autoimmunity
SocialFeb 16, 2026

B‑Cell Depletion: Rebooting Immunity to Cure Autoimmunity

"Immune Reset" Rebooting the immune system by depletion of B cells, like a reboot of a computer, to achieve cures vs autoimmune diseases https://t.co/253NtyFmCN

By Eric Topol
Women Show Higher P‑tau217 Levels and Tau Deposition
SocialFeb 16, 2026

Women Show Higher P‑tau217 Levels and Tau Deposition

p-tau217 is a breakthrough blood test for risk of developing Alzheimer's disease. Important to know there are sex differences for this biomarker, with women having higher values at baseline and more tau deposition. @JAMANeuro https://t.co/Xrr8SjsiVY https://t.co/eyDt6mgSqR

By Eric Topol
Psychedelic Shows Rapid Depression Relief in Small Trial
SocialFeb 16, 2026

Psychedelic Shows Rapid Depression Relief in Small Trial

A psychedelic quickly reduced depression (in patients with major depression disorder) in a small, double-blind placebo randomized trial @NatureMedicine https://t.co/vvug72VGBi https://t.co/Tn58rP0ufS

By Eric Topol
LLM-Edited Radiology Reports Boost Patient Understanding, Preserve Accuracy
SocialFeb 16, 2026

LLM-Edited Radiology Reports Boost Patient Understanding, Preserve Accuracy

When the LLM rewrites the radiology report, patient understanding is increased and clinical accuracy is maintained. @LancetDigitalH @curtlanglotz @smrabd https://t.co/q2UHebBQG7 https://t.co/IwZAx59brY

By Eric Topol
15‑PDGH Inhibition and Ozempic May Restore Cartilage
SocialFeb 15, 2026

15‑PDGH Inhibition and Ozempic May Restore Cartilage

Two things that may help restore cartilage —15-PDGH inhibition https://t.co/chCj9Lj5qk —Semaglutide (Ozempic), independent of weight loss https://t.co/fqbrQQYfRt https://t.co/6CRdY1QtC1

By Eric Topol
Immune System Drives the Biological Process of Aging
SocialFeb 15, 2026

Immune System Drives the Biological Process of Aging

Our immune system is the driver of the biologic process of aging. A new and comprehensive review @NatRevImmunol https://t.co/0Fm9w7U341 https://t.co/alPoABMozO

By Eric Topol
Healthy Diet Adds 2‑3 Years Lifespan, Especially Early
SocialFeb 13, 2026

Healthy Diet Adds 2‑3 Years Lifespan, Especially Early

A healthy diet, accounting for longevity-related genes, associated with 2-3 more years of life expectancy from >100,000 people followed 10.6 years, max benefit for starting at youngest age (Figure) @uk_biobank @ScienceAdvances https://t.co/Ji7Wlhj9ZA https://t.co/B6UxuE97xG

By Eric Topol
Genetic Evidence Shows BMI Directly Shapes Gut Microbiome
SocialFeb 13, 2026

Genetic Evidence Shows BMI Directly Shapes Gut Microbiome

A successful hunt of human genome variants identifying some (with MR) that provide causal evidence that BMI affects microbe composition @NatureGenet https://t.co/1uxvnFNrbK https://t.co/SuItRHAnFe

By Eric Topol
Semaglutide Linked to Higher NAION Risk in Veterans
SocialFeb 12, 2026

Semaglutide Linked to Higher NAION Risk in Veterans

Among US veterans (mean age 60) with T2 diabetes who received semaglutide (Ozempic) there was a risk of 0.3% in the first 2 years of NAION, a serious vision loss event, that exceeded SGLT-2 inhibitor drugs (graph) @JAMAOphth https://t.co/c3zDHa7OQB https://t.co/hYTxAs6ThH

By Eric Topol
Exercise Rewires Brain, Boosting Endurance in Mice
SocialFeb 12, 2026

Exercise Rewires Brain, Boosting Endurance in Mice

How exercise rewires the brain to promote endurance https://t.co/h7fiahzoAn as demonstrated in the mouse model https://t.co/DfUWadNKgt https://t.co/vhrsv1pkUs

By Eric Topol
Molecular Mimicry Links J&J Vaccine to Rare Clotting
SocialFeb 12, 2026

Molecular Mimicry Links J&J Vaccine to Rare Clotting

Cracking the case: how did adenoviral vector vaccine such as the J&J's Covid induce very rare and potentially fatal clotting, bleeding? An elegant proof of molecular mimicry—genetic background + rogue antibodies https://t.co/yp6TNE8ZQC https://t.co/NhhYDvntmT @rkhamsi @TheAtlantic https://t.co/xY7f6MVkx9 @kakape @GretchenVogel1 @ScienceMagazine

By Eric Topol
90% Want Free AI Mammograms, Yet None Receive It
SocialFeb 11, 2026

90% Want Free AI Mammograms, Yet None Receive It

Over 90% of responders believe it's time for mammography to incorporate AI for every readout, whereas close to 0% who get screened are getting that interpretation now, and at no out-of-pocket charge https://t.co/hITOBNd7pg https://t.co/x1I6Ffxfio

By Eric Topol
US Stalls Flu Vaccine, Lags China on Nasal COVID
SocialFeb 11, 2026

US Stalls Flu Vaccine, Lags China on Nasal COVID

Not only has the US blocked a significant advance for a flu vaccine, but it has done nothing, unlike China, to advance a nasal Covid vaccine that achieves mucosal immunity to block infections https://t.co/FXnaWjxkWV https://t.co/WABn5324U8

By Eric Topol
Tylenol Use in Pregnancy Shows No Increased Neurodevelopmental Risks
SocialJan 16, 2026

Tylenol Use in Pregnancy Shows No Increased Neurodevelopmental Risks

Tylenol during pregnancy is safe without increased risk of autism, ADHD, or intellectual disability of offspring A new review of the evidence just out https://t.co/Kjwp1h3PBP

By Eric Topol
Super Agers Show APOE‑ε4 Reduction, Like Healthy Controls
SocialJan 16, 2026

Super Agers Show APOE‑ε4 Reduction, Like Healthy Controls

Super Agers with intact cognitive function and the frequency of the APOE-ε4 and APOE-ε2 alleles compared with controls and people with Alzheimer’s disease https://t.co/vMYcSTVCDS

By Eric Topol
Intentional GenAI Use Can Reduce Global Health Inequities
SocialJan 16, 2026

Intentional GenAI Use Can Reduce Global Health Inequities

GenAI has the potential to worsen health inequities. In a new review @NatureHealthJnl we show that with intent, confronting the challenges, it could be just the opposite, globally @nliulab https://t.co/jwmslSVIV1 https://t.co/5q3gq9mnez

By Eric Topol
Lynch Syndrome Vaccine Shows Strong Immune Response, Safety
SocialJan 16, 2026

Lynch Syndrome Vaccine Shows Strong Immune Response, Safety

A vaccine to prevent colon cancer. Proof-of-concept for strong immune response and safety via neoantigens given to people with mutations for Lynch syndrome https://t.co/EfXDlTJlIz https://t.co/RtxfB4oGZ1

By Eric Topol
Obesity Rewires Macrophages, Triggers NLRP3 Inflammation
SocialJan 15, 2026

Obesity Rewires Macrophages, Triggers NLRP3 Inflammation

How does obesity lead to immune system dysregulation and chronic inflammation? Macrophage metabolism is rewired, with activation of the NLRP3 inflammasome @ScienceMagazine https://t.co/bkAUgOE1c2 https://t.co/It6YaXT1b5

By Eric Topol
Multimodal AI Promises Patient‑centric Mental Health, Needs Validation
SocialJan 15, 2026

Multimodal AI Promises Patient‑centric Mental Health, Needs Validation

New @ScienceMagazine A thoughtful and comprehensive review on how multimodal AI can transform mental health, with emphasis on a patient-centric approach "The successful translation of AI into clinical practice will require robust validation" https://t.co/xSACrFI0tW https://t.co/8jiV6P1vdj

By Eric Topol
He Jiankui Returns, Society Still Unready for Embryo Editing
SocialJan 15, 2026

He Jiankui Returns, Society Still Unready for Embryo Editing

The reckless human embryo genome editor, He Jiankui, known as China's Dr. Frankenstein, is back at it. "People were not yet ready to accept what I was doing." We're still not. https://t.co/UYIwWj0qf1

By Eric Topol
Long COVID Linked to Elevated P‑tau181, Alzheimer Risk
SocialJan 15, 2026

Long COVID Linked to Elevated P‑tau181, Alzheimer Risk

Not good to see the rise in p-tau181, a blood biomarker of brain inflammation tied to increased risk of Alzheimer's disease, in a prospective cohort (mean age 56 years) with #LongCovid and neurological symptoms https://t.co/XTd5qeN24e @eBioMedicine https://t.co/B1fkhoydFI

By Eric Topol
GLP‑1 Therapies
SocialJan 15, 2026

GLP‑1 Therapies

A 5★ new review of the GLP-1 drugs, what they have achieved, and where the field is headed with so many new molecules and combinations @TheLancet https://t.co/E1Xa15fk1q https://t.co/Jjmw01L5KM

By Eric Topol
Improved Survival and Return-to-Play Guidelines for Athletes
SocialJan 14, 2026

Improved Survival and Return-to-Play Guidelines for Athletes

An excellent @NEJM review of sudden cardiac death in athletes with what constitutes the appropriate workup, potential for returning to sports, and very good trend for survival over the years https://t.co/PgoBaEcbZI

By Eric Topol
AI Boosts Individual Impact, Shrinks Collective Research Breadth
SocialJan 14, 2026

AI Boosts Individual Impact, Shrinks Collective Research Breadth

How has AI impacted science? Analysis of >41m papers. A paradox: Expansion of individual's impact but contraction in breadth of topics researched collectively https://t.co/npovh0eSL8 https://t.co/iMY3cEd9LE https://t.co/iErtpnuJQR

By Eric Topol
Invisible Immune Deficits Make Low‑risk Infections Deadly
SocialJan 14, 2026

Invisible Immune Deficits Make Low‑risk Infections Deadly

Why do so many apparently healthy people die or get severely ill from infections that would be considered low risk? For one, we don't have any way of assessing a person's immune system function in the clinic https://t.co/CshtAxDep9 https://t.co/uk5nDnyjnr

By Eric Topol
CGM‑based AI Outperforms HbA1c in Predicting Diabetes, Heart
SocialJan 14, 2026

CGM‑based AI Outperforms HbA1c in Predicting Diabetes, Heart

Continuous glucose monitoring sensor data, with a foundation model, predicts risk of Type 2 diabetes and cardiovascular outcomes better than HbA1c New @Nature @segal_eran @WeizmannScience @GLutsker "66% of incident diabetes cases and 69% of cardiovascular deaths occurred in the top risk...

By Eric Topol